経カテーテル大動脈弁置換術の世界市場

経カテーテル大動脈弁置換術の世界市場は2030年までに183億米ドルに達する見込み

2023年に73億米ドルと推定される経カテーテル大動脈弁置換術の世界市場は、分析期間2023-2030年にCAGR 14.0％で成長し、2030年には183億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経大腿手技は、CAGR 14.8％を記録し、分析期間終了までに170億米ドルに達すると予測されます。鎖骨下手技セグメントの成長率は、分析期間中CAGR 7.4%と推定されます。

米国市場は20億米ドルと推定、中国はCAGR13.0％で成長予測

米国の経カテーテル大動脈弁置換術市場は2023年に20億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに27億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは13.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.9%と11.8%と予測されています。欧州では、ドイツがCAGR約9.9%で成長すると予測されています。

世界の経カテーテル大動脈弁置換術市場- 主要動向と促進要因のまとめ

経カテーテル大動脈弁置換術とは何か、なぜ重要なのか？

経カテーテル大動脈弁置換術（TAVR）は、重度の大動脈弁狭窄症（大動脈弁が狭くなって心臓からの血流が制限される状態）の治療に用いられる低侵襲手術です。TAVR手術では、通常大腿動脈からカテーテルを挿入して弁置換を行うため、開心術の必要はないです。これらの手術は、年齢や併存疾患のために従来の外科的大動脈弁置換術（SAVR）のリスクが高い患者にとって極めて重要です。TAVRは、回復時間が短く合併症のリスクが低い低侵襲の代替手段を提供し、大動脈弁狭窄症治療における患者の転帰を改善するための重要な選択肢となっています。

TAVR手技はどのように患者の転帰を向上させるのか？

TAVR治療は、重度の大動脈弁狭窄症に対してより安全で侵襲の少ない治療法を提供することで、患者の転帰を向上させます。TAVRは低侵襲であるため、従来の開心術に比べて入院期間が短く、回復が早く、痛みも軽減されます。このアプローチはまた、感染症や出血など、開心術でより一般的な合併症のリスクを最小限に抑えます。TAVRは息切れ、疲労、胸痛などの大動脈弁狭窄症の症状を緩和することにより、患者の生活の質を著しく改善することが示されています。さらに、TAVRは、特にSAVRの候補に適さない高リスク患者において、死亡率の低下と長期生存率の向上に関連しています。

なぜTAVR手技の採用が増加しているのか？

TAVR手技の採用は、いくつかの重要な要因により増加しています。世界人口の高齢化と、特に高齢者における大動脈弁狭窄症の有病率の上昇により、効果的な治療オプションに対する需要が高まっています。医療技術と画像診断技術の進歩により、TAVR手技の安全性と有効性が向上し、より幅広い患者層が利用しやすくなっています。従来の外科的アプローチに対するTAVRの利点を実証する臨床試験や研究も、医療従事者の間でTAVRが受け入れられつつある一因となっています。さらに、次世代TAVRデバイスの開発や、中リスク患者や低リスク患者を含む適応の拡大も、これらの手技の採用を後押ししています。患者の転帰とQOLの向上に重点を置くことで、大動脈弁狭窄症の好ましい治療選択肢としてのTAVRの需要がさらに高まっています。

TAVR手技市場の成長を促進する要因は？

経カテーテル大動脈弁置換術市場の成長は、いくつかの要因によって牽引されています。特に高齢化社会における大動脈弁狭窄症の有病率の増加は、効果的な治療オプションに対する大きな需要を生み出しています。TAVRデバイスと手技の技術的進歩は、これらの手技の安全性と有効性を高め、その採用を促進します。従来の外科的アプローチに対するTAVRの利点を裏付ける臨床的エビデンスは、ヘルスケアプロバイダーや患者の間でTAVRが受け入れられつつあることに寄与しています。中リスク患者や低リスク患者への使用など、TAVRの適応拡大が市場の成長をさらに後押ししています。回復時間の短縮と患者の予後改善をもたらす低侵襲手技の重視も、TAVRの需要を後押ししています。さらに、TAVRの技術と治療成績を向上させるための研究開発の継続的な取り組みや、有利な償還政策も市場拡大に大きく寄与しています。

調査対象企業の例（注目の47社）

• Abbott Laboratories
• Boston Scientific Corporation
• Bracco SpA
• Edwards Lifesciences Corporation
• Jenavalve Technology, Inc.
• Medtronic PLC
• Meril Life Sciences Pvt., Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Transcatheter Aortic Valve Replacement Procedures Market to Reach US$18.3 Billion by 2030

The global market for Transcatheter Aortic Valve Replacement Procedures estimated at US$7.3 Billion in the year 2023, is expected to reach US$18.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Transfemoral Procedure, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$17.0 Billion by the end of the analysis period. Growth in the Subclavian Procedure segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 13.0% CAGR

The Transcatheter Aortic Valve Replacement Procedures market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Transcatheter Aortic Valve Replacement Procedures Market - Key Trends & Drivers Summarized

What are Transcatheter Aortic Valve Replacement Procedures and Why are They Critical?

Transcatheter Aortic Valve Replacement (TAVR) Procedures are minimally invasive surgeries used to treat severe aortic stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart. TAVR procedures involve the insertion of a replacement valve via a catheter, usually through the femoral artery, eliminating the need for open-heart surgery. These procedures are critical for patients who are at high risk for conventional surgical aortic valve replacement (SAVR) due to age or comorbid conditions. TAVR offers a less invasive alternative with shorter recovery times and reduced risk of complications, making it a vital option for improving patient outcomes in aortic stenosis treatment.

How Do TAVR Procedures Enhance Patient Outcomes?

TAVR Procedures enhance patient outcomes by providing a safer and less invasive treatment option for severe aortic stenosis. The minimally invasive nature of TAVR results in shorter hospital stays, faster recovery times, and reduced pain compared to traditional open-heart surgery. This approach also minimizes the risk of complications, such as infections and bleeding, which are more common in open-heart procedures. TAVR has shown to significantly improve the quality of life for patients by alleviating symptoms of aortic stenosis, such as shortness of breath, fatigue, and chest pain. Additionally, TAVR is associated with lower mortality rates and better long-term survival, particularly in high-risk patients who are not suitable candidates for SAVR.

Why is the Adoption of TAVR Procedures Increasing?

The adoption of TAVR Procedures is increasing due to several critical factors. The aging global population and the rising prevalence of aortic stenosis, particularly among the elderly, create a growing demand for effective treatment options. Advances in medical technology and imaging techniques have improved the safety and efficacy of TAVR procedures, making them more accessible to a broader patient population. Clinical trials and studies demonstrating the benefits of TAVR over traditional surgical approaches have also contributed to its growing acceptance among healthcare providers. Additionally, the development of next-generation TAVR devices and expanding indications for their use, including intermediate-risk and low-risk patients, are driving the adoption of these procedures. The focus on improving patient outcomes and quality of life further propels the demand for TAVR as a preferred treatment option for aortic stenosis.

What Factors are Driving the Growth of the TAVR Procedures Market?

The growth in the Transcatheter Aortic Valve Replacement Procedures market is driven by several factors. The increasing prevalence of aortic stenosis, particularly among the aging population, creates a significant demand for effective treatment options. Technological advancements in TAVR devices and procedural techniques enhance the safety and efficacy of these procedures, driving their adoption. Clinical evidence supporting the benefits of TAVR over traditional surgical approaches contributes to its growing acceptance among healthcare providers and patients. Expanding indications for TAVR, including its use in intermediate-risk and low-risk patients, further fuel market growth. The emphasis on minimally invasive procedures that offer faster recovery times and improved patient outcomes also drives the demand for TAVR. Additionally, ongoing research and development efforts to improve TAVR technology and outcomes, along with favorable reimbursement policies, significantly contribute to market expansion.

Select Competitors (Total 47 Featured) -

• Abbott Laboratories
• Boston Scientific Corporation
• Bracco SpA
• Edwards Lifesciences Corporation
• Jenavalve Technology, Inc.
• Medtronic PLC
• Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Transcatheter Aortic Valve Replacement Procedures - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Cardiovascular Diseases
  • Growing Aging Population and Associated Heart Conditions
  • Advancements in TAVR Device Technology
  • Rising Adoption of Minimally Invasive Procedures
  • Expansion of Indications for TAVR Procedures
  • Integration of Imaging and Navigation Technologies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Transcatheter Aortic Valve Replacement Procedures Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Transfemoral Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Subclavian Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• JAPAN
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• CHINA
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: China 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• EUROPE
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• FRANCE
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: France 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• GERMANY
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Rest of Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Rest of Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Asia-Pacific Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Asia-Pacific 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030

IV. COMPETITION